Ad
related to: novartis
Search results
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar· 3 days agoAlmost a dozen pharmaceutical companies, including several major players, have lost sensitive...
Tenecteplase Beneficial in Late LVO Stroke Except EVT Access
Medscape· 22 hours agoTenecteplase improved functional outcome in patients with LVO presenting beyond 4.5 hours who had...
Triglycerides Down With ANGPTL3 RNA Interference Agent
MedPage Today· 22 hours agoAn RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual statins ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 7 days agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
May 2024 Guide To Japanese Growth Companies With High Insider Ownership
Simply Wall St. via Yahoo Finance· 23 hours agoAs of May 2024, the Japanese market has shown resilience amidst global economic fluctuations, with a...
This French start-up wants to use AI to develop new medicines more quickly
Euronews via Yahoo News· 5 days agoFrench start-up Yseop has partnered with Amazon Web Services (AWS) to use generative AI to assist...
Chutes & Ladders—CRISPR Therapeutics finds new CMO in Sanofi leader
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Exploring PeptiDream And Two More Growth Leaders With High Insider Stakes On The Japanese Exchange
Simply Wall St. via Yahoo Finance· 1 day agoAs global markets exhibit mixed signals, with Japan's Nikkei 225 and TOPIX indices experiencing...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar via Yahoo News· 3 days agoIdentity theft and phishing The affected companies are Novartis Pharmaceuticals Corporation, Bayer...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 6 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...